Less than 20% of those diagnosed with a brain tumour survive beyond five years
Brain tumour survivor takes on triathlon challenge
A brain tumour patient is diving into a triathlon challenge to help fund research into the disease.
Vanessa Fewell, 42, from Chiddingstone Causeway, near Tonbridge, will tackle the Hever Castle Triathlon to raise money for the Brain Tumour Research charity. She is motivated by her own diagnosis and is also running in memory of a close friend who died from the disease.
Vanessa was diagnosed with a grade 2 astrocytoma in February 2016 after suffering from mild symptoms of pressure in her head, when her three children Ella, Harry, and Sophia were all under the age of 12. She had surgery, chemotherapy and radiotherapy to remove the tumour and has since recovered well from her treatment.
Devastatingly, Vanessa’s diagnosis came just five months after her close friend and neighbour, Ali Smith, was diagnosed with a glioblastoma – a highly aggressive type of tumour. Ali, a beautician from Chiddingstone Causeway, had surgery, chemotherapy and radiotherapy, but passed away just 15 months later, aged 48, in January 2017. She left her husband Adam and two children.
Vanessa said: “I was devastated when Ali passed away, as were all her friends. Her funeral took place the week I began my chemotherapy and it was heart-breaking. She was the most kind, generous and caring person, with a great sense of fun and she is very missed.
“Having recovered from my treatment, and having been motivated by Ali’s loss, I decided to challenge myself and a group of friends to take on the Hever Castle Triathlon. We are looking forward to the event and we hope to raise as much money as possible to help fund research into this devastating disease.
Joining Vanessa at the event on Sunday 22nd September will be her friends Kate Grantham, Toni Young and Adrienne Bentley. The team, who are aiming to raise £1,500, are setting-off with an open-water swim in the Hever Castle lake, before heading off around the castle’s spectacular castle grounds, which date back to the 1200s.
Brain tumours are indiscriminate; they can affect anyone at any age. What’s more, they kill more children and adults under the age of 40 than any other cancer, yet just 1% of the national spend on cancer research has been allocated to this devastating disease.
Vanessa is also a keen supporter and advocate of Brain Tumour Research’s member charity, Astro Brain Tumour Fund, which funds low-grade glioma research projects and offers support to the low-grade glioma community.
Tim Green, Senior Community Fundraising Manager for Brain Tumour Research, said: “For too long, brain tumours have been a neglected cancer and stories like Ali’s remind us all that we cannot allow this desperate situation to continue. Sadly, less than 20% of those diagnosed with a brain tumour survive beyond five years compared with an average of 50% across all cancers.
“We are extremely grateful for Vanessa’s support and wish her and the team the best of luck for the triathlon. The money raised will help us in our mission to build a network of experts in sustainable research. We are funding dedicated UK Centres of Excellence, where scientists are focused on improving outcomes for patients and, ultimately, finding a cure.”
To sponsor Vanessa, please go to https://bit.ly/2NwqGZV
For further information, please contact:
Annie Slinn at Brain Tumour Research on 01908 867239 or 07591 206545 or email@example.com.
Notes to Editors
Brain Tumour Research is the only national charity in the UK dedicated to raising funds for continuous and sustainable scientific research into brain tumours, and we are a leading voice calling for greater support and action for research into what scientists are calling the last battleground against cancer.
We are building a network of experts in sustainable research at dedicated Centres of Excellence whilst influencing the Government and larger cancer charities to invest more nationally.
We welcome recent funding announcements for research into brain tumours from the UK Government and Cancer Research UK – £65 million pledged over the next five years. However, this potential funding of £13 million a year comes with a catch – money will only be granted to quality research proposals and, due to the historic lack of investment, there may not be enough of these applications that qualify for grants from this pot.
We want research funding parity with breast cancer and leukaemia. We are calling for a £30-35 million investment every year for research into brain tumours in order to fund the basic research groundwork needed to accelerate the translation from laboratory discoveries into clinical trials and fast-track new therapies for this devastating disease.
The Brain Tumour Research charity is a powerful campaigning organisation and represents the voice of the brain tumour community across the UK. We helped establish and provide the ongoing Secretariat for the All Party Parliamentary Group for Brain Tumours (APPGBT). We are supporting the crucial APPGBT 2018 Inquiry into the economic and social impacts of brain tumours and will publish their report in the autumn. We are also a key influencer in the development strategy for the Tessa Jowell Brain Cancer Mission.
Key statistics on brain tumours:
- Brain tumours are indiscriminate; they can affect anyone at any age
- Brain tumours kill more children and adults under the age of 40 than any other cancer
- Just 1% of the national spend on cancer research has been allocated to brain tumours
- In the UK, 16,000 people each year are diagnosed with a brain tumour
- Brain tumours kill more children than leukaemia
- Brain tumours kill more men under 45 than prostate cancer
- Brain tumours kill more women under 35 than breast cancer
- Less than 20% of those diagnosed with a brain tumour survive beyond five years compared with an average of 50% across all cancers
Please quote Brain Tumour Research as the source when using this information. Additional facts and statistics are available from our website. We can also provide case studies and research expertise for the media.